We are live on ! Find out more
WM

WS Management Portfolio holdings

AUM $1.14B
1-Year Est. Return 139.27%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+139.27%
3 Year Est. Return
+309.04%
5 Year Est. Return
+400.83%
10 Year Est. Return
+1,509.99%
AUM
$1.2B
AUM Growth
+$250M
Cap. Flow
+$22.8M
Cap. Flow %
1.91%
Top 10 Hldgs %
53.97%
Holding
74
New
14
Increased
12
Reduced
6
Closed
12

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$11.5M
2
RGNX icon
Regenxbio
RGNX
+$7.68M
3
WOLF icon
Wolfspeed
WOLF
+$6.03M
4
CTLT
CATALENT, INC.
CTLT
+$4.39M
5
LAMR icon
Lamar Advertising Co
LAMR
+$3.61M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$6.69M
2
WTFC icon
Wintrust Financial
WTFC
+$4.44M
3
CLF icon
Cleveland-Cliffs
CLF
+$2.4M
4
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$1.75M
5
SLN
Silence Therapeutics
SLN
+$155K

Sector Composition

Rank Sector Weight
1 Miscellaneous 50.05%
2 Financials 14.83%
3 Technology 11.85%
4 Consumer Staples 3.95%
5 Consumer Discretionary 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRN icon
51
BioMarin Pharmaceuticals
BMRN
$12.6B
$2.68M 0.22%
30,953
– –
GME icon
52
PUT
GameStop
GME
$8.19B
$2.42M 0.2%
+100,000
New +$2.25M
UBER icon
53
CALL
Uber
UBER
$157B
$2.16M 0.18%
+50,000
New +$1.86M
ASA
54
ASA Gold and Precious Metals
ASA
$1.23B
$1.82M 0.15%
122,351
– –
CLF icon
55
CALL
Cleveland-Cliffs
CLF
$6.75B
$1.68M 0.14%
+100,000
New +$1.59M
NTLA icon
56
Intellia Therapeutics
NTLA
$1.84B
$1.09M 0.09%
26,646
– –
CRSP icon
57
CRISPR Therapeutics
CRSP
$5.74B
$1.06M 0.09%
18,876
– –
MPT
58
Medical Properties Trust
MPT
$2.41B
$926K 0.08%
100,000
– –
RARE icon
59
Ultragenyx Pharmaceutical
RARE
$2.59B
$733K 0.06%
15,885
– –
WVE icon
60
Wave Life Sciences
WVE
$1.02B
$702K 0.06%
192,722
– –
CTLT
61
CALL
DELISTED
CATALENT, INC.
CTLT
$429K 0.04%
+9,900
New +$435K
EDIT icon
62
Editas Medicine
EDIT
$507M
$237K 0.02%
28,797
– –
AFMD
63
DELISTED
Affimed
AFMD
– –
-10,000
Closed -$74.6K
CLF icon
64
Cleveland-Cliffs
CLF
$6.75B
– –
-151,500
Closed -$2.4M
CVNA icon
65
CALL
Carvana
CVNA
$53.3B
– –
-750,000
Closed -$1.47M
DXCM icon
66
CALL
DexCom
DXCM
$33.7B
– –
-100,000
Closed -$11.6M
DXCM icon
67
DexCom
DXCM
$33.7B
– –
-100
Closed -$12.1K
GDX icon
68
CALL
VanEck Gold Miners ETF
GDX
$32.3B
– –
-200,000
Closed -$6.47M
KRE icon
69
State Street SPDR S&P Regional Banking ETF
KRE
$4.04B
– –
-40,000
Closed -$1.75M
SLN
70
Silence Therapeutics
SLN
$836M
– –
-25,000
Closed -$155K
TDOC icon
71
CALL
Teladoc Health
TDOC
$1.16B
– –
-150,000
Closed -$3.88M
UBER icon
72
PUT
Uber
UBER
$157B
– –
-150,000
Closed -$4.75M
WTFC icon
73
Wintrust Financial
WTFC
$10.3B
– –
-60,900
Closed -$4.44M
FSR
74
CALL
DELISTED
Fisker Inc.
FSR
– –
-300,000
Closed -$1.84M
1 2
3

Similar funds

SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
LMGAM
Liberty Mutual Group Asset Management Boston, Massachusetts $1.15B AUM 29.1% 1-Year Est. Return
GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
DWS
Discipline Wealth Solutions Greenville, South Carolina $1.15B AUM 20.96% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return

WS Management's Q2 2023 Portfolio in Review

As of Q2 2023, WS Management held 74 positions worth $1.2B, up 26% from $946M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

WS Management's Q2 2023 filing shows 14 new, 12 increased, 6 reduced and 12 closed positions. Its largest new stake was Wolfspeed: 118,400 shares worth $6.58M. The largest sale was State Street SPDR S&P Biotech ETF, an estimated $6.69M.

By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, up from 46% a quarter earlier, followed by Financials and Technology.

  • WS Management's largest Q2 2023 buy was Wolfspeed: 118,400 shares worth $6.58M.
  • WS Management added most to NVIDIA in Q2 2023, an estimated $11.5M increase.
  • WS Management's biggest Q2 2023 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $6.69M.
  • WS Management fully exited Wintrust Financial in Q2 2023, selling an estimated $4.44M.
  • WS Management's ten largest holdings make up 54% of its $1.2B portfolio in Q2 2023.
  • WS Management opened 14 new positions and closed 12 in Q2 2023.
  • WS Management's portfolio value rose 26% quarter-over-quarter to $1.2B.

Based on WS Management's 13F filing for Q2 2023, filed 10 Aug 2023.